Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Cleveland Clinic Journal of Medicine|January 5, 2002
GP IIb/IIIa inhibitors in coronary artery disease management: what the latest trials tell usD P Chew, D J MoliternoCurrent Cardiology Reports|January 5, 2001
Oral glycoprotein IIb/IIIa antagonists in coronary artery diseaseD P Chew, D L BhattJournal of the American College of Cardiology|December 29, 2000
A critical appraisal of platelet glycoprotein IIb/IIIa inhibitionD P Chew, D J MoliternoInternal Medicine Journal|June 29, 2002
Optimizing glycoprotein IIb/IIIa inhibition: lessons from recent randomized controlled trialsD P Chew, D L BhattProgress in Cardiovascular Diseases|December 1, 2001
Intravenous glycoprotein IIb/IIIa inhibition in non-ST segment elevation acute coronary syndromesD P Chew, M Roffi, E J TopolAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 20, 2004
Oral glycoprotein IIb/IIIa inhibitors: why don't they work?D P Chew, D L Bhatt, E J TopolInternational Journal of Cardiology|December 17, 2021
Outcome trial data on sodium glucose cotransporter-2 inhibitors: Putting clinical benefits and risks in perspectiveB Chiang, D P Chew, C G De PasqualeInternal Medicine Journal|May 31, 2007
Improving the management of acute coronary syndromes in Australia: translating evidence to outcomesL T Huynh, P A Phillips, D P ChewCirculation|February 24, 2001
Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists: a meta-analysis of phase III multicenter randomized trialsD P Chew, D L Bhatt, S Sapp, et al.Pageof 3